The effect of intracamerally injected ethacrynic acid on intraocular pressure in patients with glaucoma

S. Melamed, R. Kotas-Neumann, A. Barak, D. L. Epstein

Research output: Contribution to journalArticlepeer-review

Abstract

We studied the effect of ethacrynic acid on intraocular pressure in eyes with advanced open-angle glaucoma. Five to 15 μl of ethacrynic acid (3.3 to 9.8 μg) was injected intracamerally after retrobulbar anesthesia was achieved in five eyes of five patients with advanced glaucoma. Intraocular pressure before treatment ranged from 26 to 46 mm Hg with maximal medical treatment. A reduction in intraocular pressure from 9 to 31 mm Hg was observed in all patients three to 24 hours after treatment, and this effect lasted for three days, with a gradual return of intraocular pressure to pretreatment values one week after treatment. No acute corneal or anterior chamber side effects were observed and results of corneal endothelial cell counts were essentially unchanged two months after treatment. We suggest that ethacrynic acid may represent a new class of antiglaucoma medication. Intracameral administration of ethacrynic acid or a derivative might be contemplated in the future at the time of other ocular surgical procedures to treat short-term intraocular pressure increase.

Original languageEnglish
Pages (from-to)508-512
Number of pages5
JournalAmerican Journal of Ophthalmology
Volume113
Issue number5
DOIs
StatePublished - 1992
Externally publishedYes

Fingerprint

Dive into the research topics of 'The effect of intracamerally injected ethacrynic acid on intraocular pressure in patients with glaucoma'. Together they form a unique fingerprint.

Cite this